Measurable disease per FET-PET vs MRI in GBM

Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.


Отзывы


Podcastly – the best platform for podcasters and podcast lovers. More than 10 millions of audio content that available on Android/iOS/Web/Desktop and Telegram.